OGI:NSD-OrganiGram Holdings Inc (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 1.9

Change

+0.01 (+0.53)%

Market Cap

USD 0.19B

Volume

1.04M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-22 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
NBIX Neurocrine Biosciences Inc

-3.20 (-2.24%)

USD 13.68B
VTRS Viatris Inc

-0.03 (-0.26%)

USD 13.36B
ITCI Intracellular Th

-2.39 (-3.29%)

USD 7.72B
LNTH Lantheus Holdings Inc

+10.79 (+16.01%)

USD 4.49B
ALVO Alvotech

+0.03 (+0.21%)

USD 4.05B
ALKS Alkermes Plc

-0.15 (-0.62%)

USD 4.04B
AVDL Avadel Pharmaceuticals PLC

-0.01 (-0.05%)

USD 3.33B
HCM HUTCHMED DRC

+0.80 (+4.26%)

USD 3.23B
INDV Indivior PLC Ordinary Shares

+0.30 (+1.70%)

USD 2.93B
EVO Evotec SE ADR

+0.12 (+2.29%)

USD 2.51B

ETFs Containing OGI

BUDX 3.52 % 0.00 %

N/A

N/A
SEED:CA 0.00 % 1.13 %

N/A

N/A
HMMJ-U:CA Horizons Marijuana Life S.. 0.00 % 0.00 %

-0.25 (0%)

CAD 0.09B
THCX 0.00 % 0.00 %

N/A

N/A
HMMJ:CA Global X Marijuana Life S.. 0.00 % 0.86 %

-0.10 (0%)

CAD 0.08B
PSDN 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 45.04% 88% B+ 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 45.04% 88% B+ 91% A-
Trailing 12 Months  
Capital Gain -6.86% 59% D- 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.86% 59% D- 43% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -23.13% 35% F 16% F
Dividend Return -23.13% 35% F 16% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 59.96% 41% F 27% F
Risk Adjusted Return -38.58% 44% F 24% F
Market Capitalization 0.19B 57% F 48% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative earnings

The company had negative total earnings in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector